human
coronavirus
hcov
import
pathogen
caus
upper
respiratori
tract
infect
neuroinvas
abil
howev
littl
known
dynam
infect
process
cov
vivo
current
specif
antivir
drug
prevent
treat
hcov
infect
verifi
replic
abil
pathogen
report
strain
express
renilla
luciferas
rluc
mice
differ
genet
background
balbc
addit
monitor
spatial
tempor
progress
central
nervou
system
cn
live
balbc
mice
intranas
intracerebr
inocul
found
fatal
suckl
mice
intranas
inocul
viral
titer
rluc
express
detect
brain
spinal
cord
mice
infect
moreov
viral
replic
initi
observ
brain
noninvas
bioluminesc
imag
infect
spread
spinal
cord
balbc
mice
consist
tropism
cn
furthermor
rluc
readout
correl
hcov
replic
abil
protein
express
allow
quantif
antivir
activ
live
mice
addit
valid
chloroquin
strongli
inhibit
replic
vivo
result
provid
new
insight
tempor
spatial
dissemin
cn
method
provid
extrem
sensit
platform
evalu
efficaci
antivir
therapi
treat
neuroinvas
hcov
live
mice
coronavirus
cov
member
famili
coronavirida
order
nidoviral
genu
coronaviru
adam
et
al
cov
envelop
singlestrand
positivesens
rna
virus
largest
genom
among
rna
virus
kb
perlman
netland
widespread
natur
infect
varieti
speci
current
six
cov
identifi
predominantli
caus
respiratori
central
nervou
system
cn
patholog
human
usual
caus
common
cold
winter
earli
spring
larson
et
al
wherea
respons
caus
croup
children
result
sever
clinic
featur
arden
et
al
fouchier
et
al
van
der
hoek
et
al
associ
bronchiol
pneumonia
woo
et
al
woo
et
al
outbreak
sever
acut
respiratori
syndrom
sar
lethal
zoonot
cov
infect
report
china
associ
sarscov
ksiazek
et
al
sarslik
diseas
emerg
result
mortal
rate
caus
agent
identifi
middl
east
respiratori
syndrom
cov
merscov
gralinski
baric
milnepric
et
al
despit
statu
infecti
respiratori
pathogen
cov
also
damag
cn
caus
neurolog
diseas
arabi
et
al
arbour
et
al
burk
et
al
hung
et
al
morfopoul
et
al
netland
et
al
sarscov
detect
cerebrospin
fluid
patient
multipl
sclerosi
arbour
et
al
burk
et
al
hung
et
al
recent
sever
neurolog
syndrom
identifi
associ
merscov
arabi
et
al
sasrcov
reportedli
exhibit
neuroinvas
properti
cn
mice
netland
et
al
associ
fatal
enceph
morfopoul
et
al
therefor
cov
thought
respons
cn
patholog
way
similar
known
neuroinvas
virus
measl
viru
human
immunodefici
viru
herp
viru
koyuncu
et
al
recent
littl
known
process
dynam
hcov
infect
cn
effect
drug
current
avail
treat
patient
infect
therefor
easili
observ
anim
model
requir
understand
viral
replic
investig
potenti
therapeut
strategi
convent
assay
examin
hostpathogen
interact
indispens
demonstr
process
pathogen
infect
dissemin
mous
model
commonli
use
studi
viral
replic
dissemin
test
potenti
antivir
drug
howev
convent
approach
variou
limit
experiment
anim
must
anatomis
multipl
time
point
studi
site
infect
quantifi
pathogen
titer
thu
requir
larg
number
anim
moreov
approach
monitor
realtim
spatial
tempor
progress
infect
anim
bioluminesc
imag
bli
power
optic
techniqu
molecular
imag
infecti
diseas
therapi
vivo
bli
techniqu
emerg
power
complement
convent
assay
use
studi
pathogen
replic
dissemin
hutchen
luker
luker
luker
renilla
luciferas
rluc
among
wide
distribut
commonli
use
luciferas
enzym
vivo
imag
purifi
marin
organ
renilla
reniformi
sea
pansi
exhibit
bluegreen
bioluminesc
catalysi
stimul
rluc
atpindepend
oxid
coelenterazin
gener
bioluminesc
lorenz
et
al
upon
oxid
rluc
vitro
coelenterazin
produc
blue
light
peak
emiss
nm
matthew
et
al
unlik
luciferas
rluc
smaller
compon
high
specif
sensit
genet
fuse
protein
particularli
use
investig
pathogen
larg
genom
restrict
venisnik
et
al
noninvas
imag
method
monitor
viral
replic
live
anim
conveni
tempor
spatial
investig
viral
dissemin
pathogenesi
convent
assay
moreov
live
anim
monitor
differ
time
point
therebi
reduc
number
anim
requir
gener
suffici
data
use
recombin
virus
tag
luciferas
less
well
studi
becom
increasingli
popular
previous
use
recombin
rlucexpress
viru
base
backbon
screen
anticov
agent
antivir
host
factor
belong
genu
betacoronaviru
along
sever
sarscov
merscov
mcintosh
et
al
stjean
et
al
import
replicationrel
gene
conserv
includ
rdrp
rna
helicas
van
boheemen
et
al
woo
et
al
caus
mild
infect
human
caus
sever
cn
patholog
suckl
mice
manipul
biosafeti
level
facil
moreov
show
robust
growth
kinet
ident
virul
wildtyp
viru
vivo
chloroquin
cq
approv
food
drug
administr
treat
malaria
long
prescrib
prophylact
pregnant
women
risk
exposur
plasmodium
parasit
levi
et
al
cq
reportedli
exhibit
antimalari
antiinflammatori
antivir
activ
vitro
efficaci
sever
virus
includ
cov
wild
de
et
al
howev
realtim
data
concern
vivo
distribut
viral
infect
anticov
activ
live
anim
remain
limit
util
studi
time
hcov
replic
dissemin
cn
mice
verifi
cq
cov
inhibitor
vivo
use
noninvas
bli
live
mice
studi
provid
new
insight
cov
replic
dissemin
cn
offer
conveni
valuabl
method
identifi
antihcov
drug
capabl
treat
neurolog
symptom
cell
grown
dulbecco
modifi
eagl
medium
gibco
gaithersburg
md
usa
supplement
fetal
bovin
serum
gibco
mm
lglutamin
gibco
co
rabbit
monoclon
antibodi
purchas
cell
signal
technolog
danver
usa
antirabbit
antimous
igg
h
l
purchas
kpl
gaithersburg
md
usa
antirluc
rabbit
monoclon
goat
antirabbit
igg
antibodi
purchas
abcam
cambridg
uk
mous
polyclon
antibodi
prepar
laboratori
goat
antimous
igg
secondari
antibodi
purchas
life
technolog
carlsbad
ca
usa
antineun
mous
monoclon
antibodi
purchas
millipor
billerica
usa
goat
antimous
igg
h
l
secondari
antibodi
purchas
life
technolog
antimicrotubuleassoci
protein
chicken
polyclon
antibodi
goat
antichicken
polyclon
antibodi
purchas
abcam
balbc
mice
purchas
anim
care
centr
chines
academi
medic
scienc
beij
china
studi
protocol
approv
committe
ethic
anim
experi
chines
center
diseas
control
prevent
pathogenfre
mice
hous
use
accord
guidelin
chines
regul
administr
affair
concern
experiment
anim
balbc
old
old
mice
intracerebr
intranas
inocul
wt
subsequ
assay
whole
brain
spinal
cord
spleen
heart
blood
collect
mice
homogen
phosphatebuff
salin
pb
use
fastprep
instrument
mp
biomed
strasbourg
franc
centrifug
rpm
min
remov
tissu
debri
supernat
collect
aliquot
studi
brain
spinal
homogen
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
transfer
nitrocellulos
membran
block
skim
milk
room
temperatur
h
incub
mous
polyclon
antibodi
overnight
wash
pb
membran
incub
antimous
igg
kpl
antirabbit
igg
kpl
room
temperatur
h
blot
scan
detect
infrar
fluoresc
use
odyssey
infrar
imag
system
licor
bioscienc
lincoln
ne
usa
total
rna
isol
tissuehomogen
supernat
virusinfect
mice
use
trizol
reagent
invitrogen
carlsbad
ca
usa
rel
amount
viral
genom
rna
quantifi
use
qrtpcr
describ
previous
niu
et
al
follow
primer
probe
forward
revers
probe
famttccagatctacttcgcgcacatcctamra
tissu
cultur
infecti
dose
tcid
determin
indirect
immunofluoresc
assay
ifa
accord
previous
describ
method
reed
briefli
cell
plate
inocul
serial
dilut
viru
virusinfect
cell
incub
mous
polyclon
antibodi
post
infect
goat
antimous
igg
antibodi
use
secondari
antibodi
brain
spinal
cord
dissect
mice
control
mice
postinfect
dpi
fix
neutralbuff
formalin
embed
paraffin
routin
section
thick
section
permeabil
triton
pb
min
block
bovin
serum
albumin
h
room
temperatur
incub
primari
antibodi
includ
antirluc
rabbit
monoclon
antibodi
antineun
antibodi
antibodi
overnight
section
incub
secondari
antibodi
includ
alexa
fluor
goat
antirabbit
alexa
fluor
goat
antimous
igg
h
l
alexa
fluor
goat
antichicken
polyclon
antibodi
h
stain
sigmaaldrich
st
loui
mo
usa
min
section
cover
permount
imag
captur
operetta
perkinelm
waltham
usa
columbu
softwar
leica
tc
confoc
microscop
la
softwar
leica
biosystem
wetzlar
germani
replic
mice
evalu
bli
vivo
f
pro
bruker
daltonik
bremen
germani
prior
imag
mice
inject
intraperiton
renilla
luciferas
substrat
promega
madison
wi
usa
anaesthet
isofluran
min
mice
place
lighttight
camera
box
stage
continu
anesthesia
imag
acquisit
time
min
signal
quantifi
use
bruker
molecular
imag
softwar
bruker
graph
produc
use
prism
softwar
graphpad
softwar
san
diego
ca
usa
result
express
mean
standard
error
mean
statist
analysi
perform
use
spss
ibm
corp
armonk
ny
usa
differ
consid
statist
signific
p
previous
construct
sever
recombin
rlucexpress
virus
one
report
viru
gene
replac
rluc
show
robust
growth
kinet
similar
high
stabil
multipl
passag
vitro
addit
tcid
show
pathogen
balbc
mice
exhibit
neurolog
symptom
ident
caus
parent
viru
intracerebr
inocul
viral
replic
vivo
depend
genet
background
viru
host
previou
studi
report
inbr
balbc
mice
suscept
infect
jacomi
et
al
jacomi
talbot
noah
et
al
therefor
two
mous
strain
infect
tcid
intranas
inocul
order
determin
infect
respiratori
tract
vivo
expect
strain
present
typic
symptom
advanc
diseas
twitch
limb
hump
back
inocul
intranas
inocul
led
mortal
strain
mice
die
dpi
similar
infect
fig
c
addit
mous
strain
infect
show
reduc
bodi
weight
similar
infect
fig
accord
previou
report
jacomi
talbot
mice
especi
old
sensit
balbc
howev
present
studi
found
balb
c
suckl
mice
old
infect
dose
tcid
show
mortal
similar
sensit
result
show
infect
result
sever
enceph
neurolog
symptom
mous
strain
suggest
use
infect
model
simul
cn
infect
vivo
confirm
observ
dissemin
recombin
viru
viral
load
differ
tissu
determin
use
ifa
cell
realtim
qrtpcr
dpi
via
intranas
inocul
tcid
line
symptom
detect
high
viral
titer
brain
spinal
cord
mous
strain
fig
upper
wherea
low
viral
rna
level
detect
heart
spleen
extrem
low
level
detect
blood
fig
lower
consist
previou
report
et
al
jacomi
talbot
immunostain
brain
spinal
cord
section
mice
underw
intracerebr
infect
confirm
presenc
fig
rluc
detect
neuron
cell
label
neun
sever
area
cn
mous
strain
fig
result
suggest
promis
candid
bli
mous
strain
perform
bli
vivo
balbc
mice
intranas
inocul
tcid
monitor
time
bioluminesc
intens
determin
fig
dpi
signal
observ
brain
spinal
cord
dorsal
side
balbc
mice
imag
fig
wherea
signal
detect
mice
infect
data
shown
moreov
ventral
side
balbc
mice
imag
replic
observ
fig
b
surprisingli
signal
detect
brain
mice
death
dpi
howev
point
remov
fur
might
affect
photon
transmiss
dorsal
ventral
side
fig
b
confirm
replic
variou
mice
strain
lack
signal
mice
could
due
low
penetr
bioavail
rluc
substrat
mice
rather
low
viral
titer
cn
result
indict
bli
readili
visual
could
use
quantifi
replic
dissemin
cn
live
balbc
mice
suggest
viru
potenti
candid
realtim
imag
follow
inocul
use
bli
studi
time
cours
replic
dissemin
briefli
individu
balbc
mice
either
inocul
intracerebr
tcid
intranas
tcid
monitor
time
two
day
intracerebr
inocul
signal
appar
brain
dorsal
side
mice
fig
dpi
signal
detect
brain
becam
dispers
addit
signal
detect
spine
fig
simultan
infect
balbc
mice
exhibit
sever
symptom
typic
advanc
diseas
twitch
limb
die
soon
thereaft
follow
intranas
inocul
signal
eman
brain
observ
dpi
peak
dpi
wherea
signal
eman
spinal
cord
detect
dpi
fig
mice
die
dpi
verifi
whether
direct
correl
intens
viral
titer
balbc
mice
intracerebr
intranas
inocul
sacrif
differ
time
point
viral
replic
determin
indirect
ifa
brain
spinal
cord
reveal
good
correl
rel
viral
load
bioluminesc
intens
fig
g
high
level
correl
two
variabl
fig
e
h
j
particularli
intracerebralinfect
group
fig
result
confirm
efficaci
bli
assess
viral
load
mice
western
blot
analysi
fig
l
valid
time
cours
replic
brain
spinal
cord
find
indic
bli
reveal
tempor
spatial
progress
replic
live
mice
provid
noninvas
method
sensit
quantifi
small
differ
verifi
whether
bli
mice
could
use
test
effici
antivir
drug
vivo
cq
administ
mice
h
viral
inocul
day
mgkg
administ
daili
accord
previou
studi
keyaert
et
al
mice
intracerebr
infect
tcid
bioluminesc
intens
measur
daili
fig
signal
detect
mice
treat
cq
surviv
fig
lower
wherea
mice
receiv
pb
display
increas
bioluminesc
die
fig
upper
demonstr
signific
differ
rel
individu
control
fig
c
western
blot
analysi
confirm
differ
replic
mice
treat
without
cq
fig
e
result
show
mice
could
use
sensit
vivo
tool
test
effici
antivir
drug
compound
broadspectrum
cov
particularli
sever
sarscov
merscov
cov
caus
respiratori
diseas
also
associ
neurolog
complic
arabi
et
al
arbour
et
al
burk
et
al
hung
et
al
netland
et
al
even
caus
fatal
enceph
jacomi
et
al
jacomi
talbot
morfopoul
et
al
howev
mechan
respons
dissemin
penetr
host
cn
remain
unclear
therefor
easili
observ
live
anim
model
requir
identifi
mechan
hcov
infect
cn
enabl
develop
antivir
drug
treat
prevent
cov
infect
associ
sever
cn
patholog
use
bli
monitor
infect
realtim
use
report
protein
direct
correl
viral
titer
confirm
previou
observ
demonstr
possess
critic
neurotrop
neuroinvas
properti
infect
via
respiratori
tract
rluc
smaller
firefli
luciferas
fluc
use
produc
genet
fusion
protein
particularli
virus
larg
genom
like
cov
replac
rluc
impair
viralrepl
kinet
observ
robust
rluc
activ
moreov
rluc
express
level
correl
well
viral
replic
infect
cn
reveal
dynam
infect
process
therefor
result
demonstr
balbc
mice
infect
could
promis
anim
model
test
efficaci
antivir
drug
treat
mice
inocul
intranas
tcid
sacrif
dpi
tissu
supernat
analyz
viral
load
ifa
upper
cell
realtim
qrtpcr
lower
data
repres
three
independ
experi
shown
mean
standard
deviat
b
immunofluoresc
stain
infect
mockinfect
mous
brain
spinal
cord
c
doublestain
rluc
neuron
cell
brain
spinal
cord
section
mice
inocul
intranas
tcid
sacrif
dpi
brain
spinal
cord
tissu
analyz
use
operetta
perkinelm
columbu
softwar
b
leica
tc
confoc
microscop
la
softwar
c
repres
graph
shown
variou
brain
spinal
cord
section
balbc
mice
balbc
mice
intranas
infect
tcid
bli
perform
dpi
intraperiton
inject
rluc
substrat
captur
photon
emiss
use
vivo
f
pro
system
repres
graph
shown
dorsal
ventral
view
b
comparison
bli
differ
side
mice
differ
genet
background
data
repres
three
independ
experi
shown
mean
standard
deviat
fig
bli
spatial
tempor
progress
infect
bli
balbc
mice
intracerebr
intranas
f
infect
balbc
mice
underw
intracerebr
tcid
intranas
tcid
inocul
day
bli
perform
daili
intraperiton
inject
rluc
substrat
captur
photon
emiss
use
vivo
f
pro
system
repres
bli
imag
shown
data
correspond
time
cours
intracerebr
infect
luciferas
activ
quantifi
use
vivo
f
pro
system
viral
titer
determin
indirect
ifa
brain
b
spinal
cord
tissu
indic
time
point
r
pvalu
linear
regress
analysi
brain
c
spinal
cord
e
tissu
indic
graph
gj
data
correspond
time
cours
intranas
infect
luciferas
activ
quantifi
use
vivo
f
pro
system
viral
titer
determin
indirect
ifa
brain
g
spinal
cord
tissu
indic
time
point
r
pvalu
linear
regress
analysi
brain
h
spinal
cord
j
tissu
indic
graph
data
repres
three
independ
experi
shown
mean
standard
deviat
western
blot
analysi
replic
intracerebr
k
intranas
l
inocul
neurolog
symptom
expect
cq
wide
use
drug
wellknown
antimalari
effect
strongli
attenu
replic
brain
prevent
infect
spread
spinal
cord
consist
previou
studi
keyaert
et
al
acut
respiratori
syndrom
caus
viral
infect
pose
seriou
threat
public
health
due
high
morbid
mortal
rate
tregon
schwarz
notabl
extrapulmonari
symptom
describ
respiratori
virus
influenza
viru
fig
bli
allow
evalu
antivir
therapeut
live
mice
bli
balbc
mice
treat
without
cq
inocul
mice
infect
intracerebr
tcid
untreat
upper
panel
treat
lower
panel
cq
mg
kg
daili
follow
daili
bli
intraperiton
inject
rluc
substrat
captur
photon
emiss
use
vivo
f
pro
system
repres
bli
imag
one
mous
shown
compar
time
cours
bli
brain
b
spinal
cord
c
tissu
mice
treat
without
cq
inocul
luciferas
activ
quantifi
use
vivo
f
pro
system
data
repres
three
independ
experi
shown
mean
standard
deviat
western
blot
analysi
brain
spinal
cord
e
tissu
balbc
mice
treat
without
cq
inocul
human
respiratori
syncyti
viru
human
metapneumoviru
accompani
neurolog
complic
dahm
et
al
mcgavern
kang
swanson
mcgavern
differ
mous
model
establish
suscept
virus
cavallaro
maassab
liu
et
al
rameixwelti
et
al
yu
et
al
howev
model
develop
sever
cn
patholog
li
et
al
use
bli
studi
neurotrop
flavivirus
sever
damag
central
peripher
nervou
system
show
viral
rna
measur
qrtpcr
directli
correl
rluc
bioluminesc
intens
intracrani
inocul
mice
respiratori
cov
could
power
tool
gain
new
insight
neurolog
manifest
neurotrop
mechan
respiratori
virus
present
studi
data
demonstr
level
reflect
replic
brain
spread
spinal
cord
live
mice
bioluminesc
intens
directli
correl
viral
load
measur
ifa
western
blot
consist
previou
studi
et
al
jacomi
et
al
preclin
anim
model
mimic
human
pathogenesi
betacov
infect
still
urgent
need
develop
vaccin
therapi
bli
emerg
power
tool
studi
anim
model
viral
diseas
therebi
enabl
realtim
studi
viral
infect
host
immun
respons
efficaci
intervent
strategi
vivo
two
anim
model
use
bli
report
studi
relationship
cov
host
identifi
anticov
agent
fan
et
al
raaben
et
al
raaben
et
al
construct
recombin
viru
express
fluc
base
mous
cov
use
studi
viral
replic
dissemin
vivo
howev
complic
tropism
mice
fan
et
al
success
establish
human
dipeptidyl
mous
model
suscept
pseudotyp
flucexpress
merscov
allow
merscov
optic
imag
howev
pseudoviru
unabl
replic
author
could
studi
entri
process
furthermor
anim
model
suitabl
simul
patholog
cn
symptom
caus
hcov
infect
present
studi
show
blibas
anim
model
could
use
test
antivir
drug
efficaci
cn
luciferas
level
accur
repres
therapeut
effect
highlight
potenti
bli
platform
evalu
antivir
drug
treat
infect
neurolog
complic
monitor
replic
dissemin
anim
realtim
although
bli
technolog
benefici
studi
viral
replic
dissemin
inher
limit
first
hair
organ
pigment
affect
photon
transmiss
therefor
photon
flux
tissu
close
bodi
surfac
detect
easili
intern
organ
light
attenu
decreas
per
cm
tissu
contag
et
al
contag
bachmann
phenomenon
explain
abl
detect
strong
signal
dorsal
rather
ventral
side
infect
mice
second
limit
biodistribut
rapid
metabol
kinet
higher
background
level
restrict
use
bli
molecular
imag
bhaumik
gambhir
pichler
et
al
tannou
et
al
therefor
genet
background
host
taken
account
even
permiss
viru
present
studi
signal
detect
cn
balbc
mice
inocul
despit
fact
balbc
mice
permiss
might
due
bioavail
rluc
substrat
might
absorb
transport
point
infect
rlucexpress
virus
pichler
et
al
limit
could
potenti
overcom
replac
rluc
report
fluc
contag
bachmann
raaben
et
al
cq
test
success
sever
anim
model
found
protect
suckl
mice
surviv
rate
follow
administr
prepartum
pregnant
mice
infect
keyaert
et
al
moreov
surviv
rate
observ
balbc
mice
infect
avian
influenza
viru
follow
treatment
mgkgday
cq
yiwu
et
al
cq
wide
distribut
throughout
bodili
tissu
fluid
higher
concentr
brain
plasma
present
studi
vivo
data
demonstr
cq
could
inhibit
hcov
cn
anim
differ
mechan
describ
inhibit
viral
infect
cq
savarino
et
al
howev
exact
mechan
cq
affect
cn
anim
requir
studi
summari
develop
power
method
realtim
monitor
replic
dissemin
cn
best
knowledg
first
report
noninvas
bli
cn
live
hcovinfect
mice
furthermor
bli
promis
platform
noninvas
screen
antivir
compound
vivo
develop
new
therapeut
strategi
studi
contribut
futur
studi
covhost
interact
vivo
screen
broadspectrum
drug
new
approach
studi
cn
patholog
caus
respiratori
virus
author
declar
commerci
financi
conflict
interest
